Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: dimethyl fumarate

Withdrawing DMF in early pregnancy does not increase relapse risk in pregnant patients with MS

Presented By
Prof. Doriana Landi, University of Rome Tor Vergata, Italy
Conference
EAN 2023

7 September, 2023 11:12

Dimethyl fumarate reduces the risk of a first clinical event in RIS

Presented By
Prof. Darin Okuda, University of Texas Southwestern Medical Center, TX, USA
Trial
Phase 4, ARISE
Conference
ECTRIMS 2022

20 December, 2022 09:14

Comparing real-world effectiveness of DMTs

Presented By
Prof. Marcello Moccia, University College London, UK
Conference
ECTRIMS 2022

20 December, 2022 09:05

Personality trait alterations in MS patients

Presented By
Dr Laura Chu, Memorial University of Newfoundland, Canada
Conference
ECTRIMS 2021

9 December, 2021 15:49

Rituximab most effective initial MS therapy in Swedish real-world study

Presented By
Mr Peter Alping, Karolinska Institutet, Sweden
Trial
Phase 4, COMBAT-MS
Conference
ECTRIMS 2021

9 December, 2021 14:36

ECTRIMS-EAN consensus on vaccination in MS patients

Presented By
Dr Mauricio Farez, Fundacion FLENI, Argentina
Conference
ECTRIMS 2021

9 December, 2021 10:35

MS therapies influence COVID-19 severity

Conference
AAN 2021

16 June, 2021 11:42

Risk of COVID-19 not increased in MS patients

Conference
MS Virtual 2020

25 November, 2020 17:10

Anti-CD20 DMTs associated with worse COVID-19 outcomes

Conference
MS Virtual 2020

25 November, 2020 17:09

Safety and efficacy of dimethyl fumarate: 13 years of follow-up

Trial
ENDORSE, DEFINE, CONFIRM
Conference
MS Virtual 2020

25 November, 2020 17:00

Safety and efficacy of cladribine, glatiramer acetate, and more

Trial
CLASSIC-MS, OPTIMUM
Conference
MS Virtual 2020

25 November, 2020 16:55

Switching from natalizumab to moderate- versus high-efficacy DMT

Presented By
Dr Carrie M. Hersh, Cleveland Clinic Lerner College of Medicine, OH, USA
Conference
EAN 2020

10 September, 2020 12:17

Treatment escalation over induction therapy

Presented By
Dr Emmanuelle Waubant, University of California, San Francisco, USA
Conference
ECTRIMS 2019

8 November, 2019 22:40

Foetal/child perspective: risks related to drug exposure and breastfeeding

Presented By
Dr Kerstin Hellwig, Ruhr-Universität Bochum, Germany
Conference
ECTRIMS 2019

8 November, 2019 22:29

New compounds for MS treatment

Trial
Phase 2, RADIUS-R, RADIUS-D
Conference
AAN 2019

30 July, 2019 21:10

Sequencing of high-efficacy disease-modifying treatments in MS

Trial
OCTAVE
Conference
AAN 2019

30 July, 2019 20:12

Fumarates and vitamin A derivatives advance and latest insights in non-biologic systemic therapeutic agents in psoriasis and atopic dermatitis

Presented By
Prof. Peter van de Kerkhof, Radboud University Medical Center, the Netherlands
Conference
SPIN 2019

21 June, 2019 18:02
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy